EFSA J. 2023 Mar 6;21(3):e07867. doi: 10.2903/j.efsa.2023.7867. eCollection 2023 Mar.
Antimicrobial resistance (AMR) data on zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs) and reporting countries, jointly analysed by EFSA and ECDC and presented in a yearly EU Summary Report. This report provides an overview of the main findings of the 2020-2021 harmonised AMR monitoring in spp., and in humans and food-producing animals (broilers, laying hens and turkeys, fattening pigs and bovines under 1 year of age) and relevant meat thereof. For animals and meat thereof, indicator data on the occurrence of AMR and presumptive Extended spectrum β-lactamases (ESBL)-/AmpC β-lactamases (AmpC)-/carbapenemases (CP)-producers, as well as the occurrence of methicillin-resistant are also analysed. In 2021, MSs submitted for the first time AMR data on isolates from meat sampled at border control posts. Where available, monitoring data from humans, food-producing animals and meat thereof were combined and compared at the EU level, with emphasis on multidrug resistance, complete susceptibility and combined resistance patterns to selected and critically important antimicrobials, as well as and isolates exhibiting ESBL-/AmpC-/carbapenemase phenotypes. Resistance was frequently found to commonly used antimicrobials in spp. and isolates from humans and animals. Combined resistance to critically important antimicrobials was mainly observed at low levels except in some serotypes and in in some countries. The reporting of a number of CP-producing isolates (harbouring , , and genes) in pigs, bovines and meat thereof by a limited number of MSs (4) in 2021, requests a thorough follow-up. The temporal trend analyses in both key outcome indicators (rate of complete susceptibility and prevalence of ESBL-/AmpC- producers) showed that encouraging progress have been registered in reducing AMR in food-producing animals in several EU MSs over the last years.
欧盟成员国(MSs)和报告国每年收集来自人类、动物和食物中的人畜共患病原体及指示菌的抗菌药物耐药性(AMR)数据,由欧洲食品安全局(EFSA)和欧洲疾病预防控制中心(ECDC)联合分析,并呈现在年度欧盟总结报告中。本报告概述了2020 - 2021年对[具体物种1]、[具体物种2]以及人类和食用动物(肉鸡、蛋鸡和火鸡、育肥猪和1岁以下牛)及其相关肉类进行的统一AMR监测的主要结果。对于动物及其肉类,还分析了AMR发生情况以及推定的超广谱β-内酰胺酶(ESBL)/AmpCβ-内酰胺酶(AmpC)/碳青霉烯酶(CP)产生菌的指示数据,以及耐甲氧西林[具体物种]的发生情况。2021年,成员国首次提交了在边境管制站采集的肉类中[具体物种]分离株的AMR数据。在可行的情况下,将来自人类、食用动物及其肉类的监测数据在欧盟层面进行汇总和比较,重点关注对选定的和至关重要的抗菌药物的多重耐药性、完全敏感性和联合耐药模式,以及表现出ESBL/AmpC/碳青霉烯酶表型的[具体物种1]和[具体物种2]分离株。在[具体物种1]以及来自人类和动物的[具体物种2]分离株中,经常发现对常用抗菌药物耐药。除了某些[具体物种1]血清型和一些国家的[具体物种2]外,对至关重要的抗菌药物的联合耐药性主要在低水平观察到。2021年,少数成员国(4个)报告了猪、牛及其肉类中一些产生CP的[具体物种2]分离株(携带[具体基因1]、[具体基因2]和[具体基因3]),需要进行深入跟踪。两个关键结果指标(完全敏感性率和ESBL/AmpC产生菌的流行率)的时间趋势分析表明,在过去几年中,几个欧盟成员国在降低食用动物中的AMR方面取得了令人鼓舞的进展。